as 11-21-2024 10:39am EST
Stocks
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | LA JOLLA |
Market Cap: | N/A | IPO Year: | 2023 |
Target Price: | $4.75 | AVG Volume (30 days): | 602.1K |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.23 | EPS Growth: | N/A |
52 Week Low/High: | $0.44 - $5.75 | Next Earning Date: | 11-12-2024 |
Revenue: | N/A | Revenue Growth: | -73.66% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
TSBX Breaking Stock News: Dive into TSBX Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
GlobeNewswire
16 days ago
TipRanks
a month ago
MT Newswires
a month ago
BioPharma Dive
a month ago
GlobeNewswire
a month ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
The information presented on this page, "TSBX Turnstone Biologics Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.